 |
Catherine Lemay
Catherine Lemay‘s practice focuses on the
drafting and prosecution of pharmaceutical, biochemical, and
chemical patent applications in Canada and around the world.
She works closely with clients ensuring that the drafting and
prosecution of their patent applications support their
business objectives. Catherine also advises clients on issues
relating to the Patented Medicines (Notice of Compliance)
Regulations and Food and Drug Regulations, particularly on
issues relating to patent listing requirements and data
protection/exclusivity.
Prior to joining MBM, Catherine worked at
Health Canada in the Office of Patented Medicines and Liaison
where she provided expert advice to senior management and drug
review bureaux on the interpretation and application of the
Food and Drug Regulations and the Patented Medicines (Notice
of Compliance) Regulations. In her position at Health Canada,
Catherine was also closely involved in the
coordination/preparation of affidavits and pleadings for
numerous judicial review applications before the Federal Court
of Canada. Catherine also spent two years working in the
corporate patent department of a multinational pharmaceutical
company in Berlin, Germany, where she was responsible for all
patent aspects relating to a number of drug research and
development projects in the field of oncology, including the
drafting and prosecution of patent applications before the
European Patent Office. Catherine completed her articling
period at a Canadian law firm specializing in intellectual
property and business Law.
Catherine is a member of the Law Society
of Upper Canada (Ontario) and the Quebec Bar (Barreau du
Québec) and practices in both English and French.
Education
- B.Sc., Honours Chemistry, University of Ottawa
- LL.L., University of Ottawa
- LL.B., University of Ottawa
Professional Involvement
- Law Society of Upper Canada (Ontario)
- Barreau du Québec
- Intellectual Property Institute of Canada (IPIC)
|
